home-hospital Hospital-level care for acutely ill adults in the comfort of their own home.
Learn more
home-hospital
Hospital-level care for acutely ill adults in the comfort of their own home. Learn more

When you see each
patient a million
times a day...

...You see the
bigger picture.

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition designed to help clinicians predict and prevent deterioration before it happens.

When you see each patient a million times a day... You see the bigger picture.

animation_heads_circle_01
animation_heads_circle_02
animation_heads_circle_03
animation_heads_circle_04
animation_heads_circle_05
wave_m

Every second, our FDA-cleared AI-based ecosystem compares 20+ physiological signals* from a wearable biosensor with data from millions of other chronic patients. The result? Powerful pattern recognition that helps predict and prevent deterioration before it happens.

wave_trans

We're powering personally predictive care...
so everyone can see better outcomes.

What if patients suffering from heart failure, COPD, chronic pain, or cancer could spend less time in hospitals and more time feeling confident and cared for at home? What if networks, clinicians, and payers could turn fewer readmissions into a higher level of care for all? And what if drug companies could more dramatically demonstrate, in real-time, the physiological impact and value of pharmacotherapy candidates?

At Biofourmis, we use patient physiology data and advanced analytics to turn those "what-ifs" into "ah-has" for some of the world's most respected healthcare providers and pharmaceutical companies—collaborators like Novartis, Chugai, Brigham and Women's Hospital, and Mayo Clinic that use our clinically validated, predictive platform to more precisely manage, intervene, and treat chronic patients in a way that's proactive and liberating. That's the power of personally predictive care.

Get To Know Us

The Biovitals® platform shows you more than patient data.
It can help show you patient futures.

ProductLineup

Our Biovitals® platform collects and interprets vast amounts of population metadata and compares it to real-time patient physiological signals to provide a clearer picture of chronic patients and their disease trajectory—a real-time picture designed to help clinicians predict and prevent serious medical events. Its actionable insights powered by machine learning, deep neural networks, and a clinical-grade Everion® wearable.

See How Biovitals® Works

Predict and prevent costly medical events with a modular, user-friendly platform.

Biovitals® delivers actionable information by bringing disease, data, machine-learning, and clinical-grade hardware together in one customizable ecosystem. Learn how we can tailor Biovitals® to improve real-world outcomes for the unique needs of health systems, payers and pharmaceutical companies.

Hospitals Icon Created with Sketch.
Payors Icon Created with Sketch.
Pharma Icon Created with Sketch.

Health Systems

  • Improve clinical outcomes by reducing readmissions and ED visits
  • Improve workflow efficiencies, care team capacity and ongoing communication with patients
  • Realize more rapid personalized treatment and communication for efficient management of patients with complex chronic conditions

Payers

  • Reduce overall healthcare expenditures while improving clinical outcomes
  • Improve quality of life for members with complex chronic conditions
  • Deliver members more targeted and timely intervention and engagement support based on their personalized needs

Pharmaceutical Companies

  • Augment drug efficacy and outcomes using drug + digital intervention
  • Accelerate development time frames by accelerating clinical trials using digital tools
  • Increase patient share, adherence, and engagement
  • Increase reimbursements and/or value-based payments
Hospitals Icon Created with Sketch.

Health Systems

Payors Icon Created with Sketch.

Payers

Pharma Icon Created with Sketch.

Pharmaceutical Companies

Proven clinical outcomes.

American Heart Association, American Stroke Association. Cardiovascular Disease: A Costly Burden for America — Projections Through 2035. Published November 2016.

Around the world and across multiple collaborations and studies, our disease prediction products are helping clinical teams see patients like never before.

Interested in learning more? Download a PDF with detailed study results.

Hospital-level Care At Home Arrhythmia Detection By Deep Learning Remote Monitoring in Cancer Patients

Collaborators and Investors

We're proud to collaborate with some of the world's most respected healthcare organizations, research hospitals, and biopharma companies. Together, we're improving patient outcomes, advancing clinical research, reducing healthcare costs, and accelerating drug research and development.

COLLABORATORS

novartis
chugai
mundipharma
astrazeneca
mayo-clinic
mass-general
bwh
singhealth
cersi
nsw
hku
univHongkong
imagineMIC

INVESTORS

sequioa
massmutual
edbi
openspace
spesnet
SGinnovate
aviva

Biofourmis in the news.

Let's get you up to speed.

Press Release
Biofourmis' AI-Powered Remote Monitoring Platform to Provide New Insights to Fight COVID-19 in Disease Monitoring Program in Hong Kong

Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today that its technology is being leveraged in a remote monitoring and disease surveillance program in Hong Kong involving patients with diagnosed or suspected novel coronavirus disease (COVID-19). The program–administered by The University of Hong Kong–also includes Hong Kong-based Harmony Medical Inc., which is Biofourmis' joint venture partner for the China region.

March 4, 2020

Press Release
Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model

Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, and ImagineMIC™ announced a partnership agreement today to drive improved outcomes and lower healthcare costs for patients with chronic conditions. ImagineMIC™ is a revolutionary medical device company that delivers chronic care management through remote monitoring services and HIPAA-compliant technology.

January 30, 2020

Press Release
Biofourmis Names Pharma and Tech Veterans as COO and CTO

Biofourmis, a fast-growing global leader in digital therapeutics that powers personally predictive care, has named two highly experienced and skilled business leaders with deep, highly relevant backgrounds as the company's chief operating officer (COO) and chief technology officer (CTO).

January 27, 2020

Press Release
Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions

Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has reached an agreement to acquire Zurich, Switzerland-based Biovotion AG, a leading developer of a cutting-edge clinical-grade wearable biosensor platform. The acquisition includes all of Biovotion's assets, including the market-leading Everion® biosensor and more than 60 global patents covering most of the wearable and sensor technology that exists for the arm or hand.

November 18, 2019

Biofourmis News

Let's connect.

We're helping some of the most respected names in healthcare deliver measurably better outcomes. Let us show you what personally predictive care can do for your organization.

Contact Us